IPO Announced
Odyssey Therapeutics IPO
US$279m raised
Lodged 7 May 2026 · NASDAQ: ODTX · US$18.00 cash per share
Advisers
Lead managers
- Joint lead manager
- Wedbush Securities (co)Oppenheimer & Co. (co)
- Bookrunner
- J.P. Morgan
(co)Cantor Fitzgerald
(co) - Legal adviser
- Issuer
- Odyssey Therapeutics
- Issuer based in
- United States
- Sector
- Biotech
- Tags
- Biotech, Drug Development
Similar deals
- Caldera Therapeutics placement Jul 2026 · US$278m · Biotech
- Attovia Therapeutics IPO Aug 2026 · US$289m · Biotech
- Slate Medicines placement Aug 2026 · US$245m · Biotech
- Avere Therapeutics placement Jul 2026 · US$320m · Biotech
- JATT II Acquisition Corp placement Jun 2026 · US$225m · Biotech
Sources
- 7 May 2026 Odyssey Therapeutics Announces $279 Million Upsized IPO, Concurrent $25 Million Private Placement cooley.com
- 8 May 2026 Final IPO prospectus (424B4), Odyssey Therapeutics, Inc. sec.gov
